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Abstract
Background: Steroid 21-hydroxylase deficiency is the most common cause of congenital adrenal
hyperplasia (CAH). Detection of underlying mutations in CYP21A2 gene encoding steroid 21-
hydroxylase enzyme is helpful both for confirmation of diagnosis and management of CAH patients.
Here we report a novel 9-bp insertion in CYP21A2  gene and its structural and functional
consequences on P450c21 protein by molecular modeling and molecular dynamics simulations
methods.
Methods: A 30-day-old child was referred to our laboratory for molecular diagnosis of CAH.
Sequencing of the entire CYP21A2 gene revealed a novel insertion (duplication) of 9-bp in exon 2
of one allele and a well-known mutation I172N in exon 4 of other allele. Molecular modeling and
simulation studies were carried out to understand the plausible structural and functional
implications caused by the novel mutation.
Results: Insertion of the nine bases in exon 2 resulted in addition of three valine residues at codon
71 of the P450c21 protein. Molecular dynamics simulations revealed that the mutant exhibits a
faster unfolding kinetics and an overall destabilization of the structure due to the triple valine
insertion was also observed.
Conclusion: The novel 9-bp insertion in exon 2 of CYP21A2 genesignificantly lowers the structural
stability of P450c21 thereby leading to the probable loss of its function.
Background
Congenital adrenal hyperplasia (CAH; OMIM# 201910)
is an autosomal recessive disorder caused by deficiency of
one of the five steroidogenic enzymes involved in cortisol
biosynthesis. Steroid 21-hydroxylase deficiency accounts
for about 90–95% of all CAH cases [1]. Deficiency of cor-
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tisol results in excessive production of androgens leading
to prenatal virilization in females and rapid somatic
growth in both sexes [2]. CAH has been traditionally
divided into three forms; severe salt wasting (SW), less
severe simple virilizing (SV) and asymptomatic non-clas-
sic (NC) form. The SW form is common and found in
75% of all CAH patients. In addition to decreased cortisol,
aldosterone biosynthesis is also impaired in these patients
resulting in severe renal salt loss and hypotonic shock,
unless treated during the neonatal period [2]. Patients
with SV form do not have aldosterone deficiency and thus
salt loss is not present. Symptoms like variable degree of
ambiguous genitalia in females, growth acceleration and
pseudoprecocious puberty are seen in SV forms. The
milder non-classical form is asymptomatic at birth and
presents with various degrees of late onset features of
hyperandrogenism.
The wide spectrum of clinical manifestations seen in this
disorder is due to varied degrees of enzyme activity caused
by different mutations in the CYP21A2 gene encoding the
steroid 21-hydroxylase enzyme. Although, both large and
point mutations have been seen in different populations
[3-7], point mutations constitute a larger proportion. The
CYP21A2 gene is part of a complicated structure, referred
to as the RCCX-module located in human leukocyte anti-
gen class III locus on chromosome 6p21.3 [8]. Approxi-
mately 30 kb upstream of CYP21A2, a pseudogene
(CYP21A1P) is present; which is 98% identical to
CYP21A2. CYP21A1P cannot synthesize the functional
protein due to presence of numerous deleterious muta-
tions.
About 95% of the mutated alleles in patients with steroid
21-hydroxylase deficiency are generated by transfer of
DNA sequences from CYP21A1P to CYP21A2 by gene con-
version events [9]. The remaining 5% alleles have new/
rare mutations due to random events [2]. The number of
rare mutations identified has increased dramatically in the
last few years [10]. Most of these mutations are unique to
individual families but some are population specific [11-
13]. Functional characterization of most of the mutants
using site directed mutagenesis followed by in vitro expres-
sion analyses have been helpful in correlating clinical
severity to the degree of loss of enzyme function caused by
the mutations [10]. However such studies are difficult to
perform in routine laboratory set up with limited
resources. Alternatively, these experimental assays could
be complemented with computational studies; wherein
the structural and functional perturbations of a protein by
virtue of mutation/s could be predicted. Consequence of
single mutation (W62G) on structural stability of lys-
ozyme [14] and structural perturbations caused by three
different activating mutations of the hLHR gene found in
four unrelated Brazilian boys with male-limited preco-
cious puberty have been studied by MD simulations [15].
Computational scientists have also used MD simulations
to independently explore the role of mutations on protein
stability and activity [16-22]. In the present study, molec-
ular modeling and MD simulations were carried out to
understand the structural and probable functional impli-
cations of the triple valine insertion of human P450c21.
Materials and methods
Clinical history of proband
The proband presented on day 30 with ambiguous genita-
lia and failure to thrive. She was the first child born of
non-consanguineous marriage with an uneventful ante-
natal history. She was born at full term by normal deliv-
ery. Her clinical examination showed prominent phallus
with clitoral hypertrophy and partial fusion of labia
(Prader stage IV). Gonads were non-palpable. Genitogram
and panendoscopy revealed normal bladder, common
urogenital sinus, vagina, and uterine cervix. Her weight
was initially 2.9 kg (well below the 0.4th centile). Later at
12 weeks her length was 54.7 cm (2nd centile) and weight
4.3 kg (2nd centile). Hormonal examination revealed ele-
vated 17-hydroxyprogesterone (17-OHP) (8800 ng/dl;
normal value < 630 ng/dl), testosterone (1.5 ng/ml; nor-
mal range 0–0.28 ng/ml) and low cortisol (5.6 ug/dl; nor-
mal range 11–18 ug/dl). Sodium and potassium levels
were 138 mmol/l and 6.1 mmol/l respectively. Her chro-
mosomal analysis revealed 46, XX normal karyotype. She
was diagnosed as simple virilising CAH and put on a rela-
tively low dose of 5 mg/m2 of hydrocortisone and 50 μg
of fludrocortisone daily. In second year, she showed nor-
mal development with 17-OHP level of 560 ng/dl. Her
weight was 8 kg, height – 74 cm and head circumference
– 45.3 cm (all below 0.4th centile). Her bone age was nor-
mal. She was continued with the same dose till her third
year. Thereafter her dose had to be increased to 9 mg of
hydrocortisone and 100 μg of fludrocortisone daily due to
increased level of 17-OHP (7200 ng/dl). She is now 5 yrs
old and developing normally.
Molecular analysis
Informed consent was obtained from both parents and
the study was approved by the Ethical Committee of our
institution. About 2 ml of whole blood was collected in
EDTA vacutainers (Becton-Dickinson, USA) for CYP21A2
gene analysis and DNA was extracted using Qiagen kit
(QIAmp DNA Blood Kit, QIAGEN GmbH, Hilden). 200
ng of genomic DNA was subjected to selective amplifica-
tion of CYP21A2 gene in two different fragments of 1.2
and 2.3 kb respectively using previously described primers
[23]. PCR was carried out in 2720 thermocycler (Applied
Biosystem) in a reaction volume of 50 μl containing 1.5
mM MgCl2, 0.2 mM dNTPs, 200 mM (NH4)2SO4, 750
mM Tris-HCl (pH 8.8), 0.1% Tween 20, 2 units of Taq
polymerase (Fermentas, Life Sciences) and 0.5 μM ofJournal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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primers. PCR was performed at 96°C for 3 min for initial
denaturation followed by 30 cycles of 95°C for 1 min,
55.5°C for 25 sec, and 72°C for 3 min and final extension
at 72°C for 6 min. PCR products were resolved on 1% aga-
rose gel stained with ethidium bromide, visualized under
UV transilluminator.
The PCR products were purified using QIAGEN kit
(QIAmp Gel Purification Kit, QIAGEN GmbH, Hilden).
Purified products were subjected to direct sequencing
with ten different primers (Table 1) based on dideoxynu-
cleotide terminator methodology using the BigDye Termi-
nator Cycle Sequencing Ready Reaction kit (PE, Applied
Biosystems, Perkin Elmer Corp., Foster City, CA). The
analysis was carried out in the ABI PRISM 3130 Genetic
Analyser (PE, Applied Biosystems). The numbering of the
nucleotides was according to Higashi et al [24].
Web-based tools
The web-based tools were used for the purpose of second-
ary structure prediction, template recognition, model
evaluation and sequence analysis (Table 2).
Secondary structure prediction
GeneSilico metaserver, JPRED and SYMPRED servers [25-
27] were used to predict the secondary structures of
human P450c21 (Table 2). The output of each of these
secondary structure prediction servers is the consensus
secondary structure predicted for the protein based on a
collection of independent algorithms. The SYMPRED
result is based on the consensus formed by the predictions
of HD, PROF, SSPRO, YASPIN, JNET and PSIPRED pro-
grams while GeneSilico result is based on PSIPRED and
JNET.
Identification of suitable template
FUGUE (v2.s.07; Table 2) was used for identification of
template for modeling the structure of human P450c21
[28]. The best template is identified based on their Z-
scores. The templates which have a Z-score of 6 or more
are labeled as "certain" with 99% confidence.
Assessment of the theoretical structure available for 
human P450c21
The theoretical structure of human P450c21 (PDB ID:
2GEG) has been elucidated using rabbit P4502c5 (PDB
ID: 1N6B) as template [29]. The quality of this theoretical
structure was assessed in two ways. Firstly, using the align-
ment of the target-template provided by FUGUE, the
agreement between the predicted consensus secondary
structure of human P450c21 with that of rabbit P4502c5
secondary structure was compared. Secondly, the quality
of the theoretical model was evaluated using Verify3D
[30] and Colorado3D server [31] (Table 2).
Generation of structure for the mutant
The structure of mutant (MT) was modeled using the the-
oretical structure of wild-type (WT; 2GEG) as the tem-
plate. Discovery Studio v 1.7 (Accelrys) was used for
building the homology-based model.
MD simulations
MD simulations were performed using GROMACS 3.3.1
[32]. United atom representation was used except for
polar and aromatic ring hydrogen atoms. GROMOS96
forcefield was used for energy calculations. Van der Waals
interactions were calculated with a distance cut-off of 0.9
nm. Electrostatic interactions were treated using the cut-
off method [33]. Neutralizing counter ions were added
when charged residues were present. The models were sol-
vated with SPC water molecules [34] and simulated in a
triclinic box [35,36] with periodic boundary conditions.
The simulations were performed in the canonical NVT
ensemble. The models were first energy minimized using
steepest descent algorithm with a tolerance of 1 J mol-1
nm-1; this was followed by position restrained MD simu-
lations for 10 ps. Initial velocities were generated con-
forming to Maxwell velocity distribution. A time step of
integration of 2 fs was used. LINCS algorithm was used to
Table 1: List of primers used for sequencing the entire CYP21A2
Primer Primer sequence Nucleotide Number Size Location
1F 5' aca gtc tac aca gca gga gg3' -78–(-59) 20 Promoter
1R 5' gtg agg gcc aga gcg aga t 3' 214–232 19 Intron 1
2F 5' gag gac cat tga tga agc 3' 322–339 18 Exon 2
2R 5' ctc aca gaa ctc ctg ggt ca 3' 806–825 20 Exon 3
4F 5' cct gtc ctt ggg aga cta ct 3' 700–719 20 Exon 3
4R 5' gtc cac aat ttg gat gga cca 3' 1187–1207 21 Exon 5
6R 5' agc aat gct gag gcc ggt ag 3' 1460–1479 20 Intron 6
7F 5' att gct atg agg cgg gtt c3' 1474–1492 19 Intron 6
8F 5' ctc act ggg ttg ctg agg gag 3' 1901–1921 21 Intron 7
9F 5' ctt cag cat ctc cgg cta c 3' 2238–2256 19 Intron 8
10R 5' ctg tgt tta cag ggg gga 3' 2778-2796 18 Intron 10Journal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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constrain the bonds [37]. The productive run was initiated
for 10 ns; this duration was sufficient to compare the sta-
bilities of the protein structures. The simulations were per-
formed at 300K.
Analysis of MD trajectories
With an objective of understanding the structural and
functional implications of the triple valine insertion, tra-
jectories of WT and MT were analyzed for the following
structural properties as a function of time: a) Potential
energy, b) The root mean square deviation (RMSD) of the
Cα atoms with respect to the starting conformation, c)
RMSD of the hydrophobic residues postulated to be
involved in membrane binding [29] with respect to the
starting conformation d) Distance between the Cα atoms
of residues S108 and D287; both of which are suggested
to be involved in heme and substrate-binding [29], e)
Structural perturbations near the insertion site. The trajec-
tories of the simulations were plotted using XMGRACE
[38]. DSSP [39] program was used for secondary structure
assignment and MolScript [40] was used to create and
render the molecular images.
Sequence logo
For understanding the conservation of residues in the
immediate vicinity of the insertion, a sequence logo was
constructed using the program WebLogo [41]. Proteins
that share more than 30% similarity with human P450c21
and are deposited in the SwissProt database were identi-
fied using the PSI-BLAST algorithm [42]. The 50 identified
homologs were all cytochromes and shared similarity
throughout the length of the protein. These proteins were
then subjected to multiple sequence alignment using
CLUSTALW [43] and a sequence logo was constructed.
Results
Mutational analysis
Clinical and biochemical findings in our patient were
consistent with her simple virilizing phenotype. Entire
sequencing of CYP21A2  gene (including 10 exons, 9
introns and < 400 base pairs upstream to the transcription
initiation codon) was performed in order to detect known
and unknown mutations. Electropherogram showed a
known I172N mutation in exon 4 of one allele and an in-
frame insertion of 9-bp TGTGGTGGT at nucleotide 306 in
exon 2 of other allele (Fig. 1A). This 9-bp insertion
resulted in triple valine insertion between V70 and L71 of
the wild type P450c21 (Fig. 1B). Re-sequencing of Exon 2
using reverse primer 2R (Table 1) showed a frameshift 9-
bp away from the frameshift seen in the forward strand.
Using SeqScape v2.1.1, forward and reverse sequences
were aligned against the reference sequence (see Addi-
tional file 1 part A) that confirmed the insertion as high-
lighted sequences (see Additional file 1 part B). The shift
in the insertion site was clearly observed in the forward
(see Additional file 1 part C) and reverse (see Additional
file 1 part D) strand that further confirmed this insertion
as duplication of TGTGGTGGT base pairs in exon 2, at
nucleotide position 306 of CYP21A2 gene (see Additional
file 1 part E). This novel insertion mutation was inherited
from the father, while the I172N was inherited from the
mother, but both parents were heterozygous for their
respective  CYP21A2  mutation and, therefore, clinically
healthy. This insertion/duplication in exon 2 is novel
(GenBank accession no. EF661662) and has not been
reported previously in patients with 21-hydroxylase defi-
ciency. This mutation was not found in 100 control sub-
jects.
In silico studies were performed to understand the effect of
the insertion of triple valine on the structure and function
of P450c21.
Effect on sequence conservation
The first step towards elucidating the effect of the inser-
tion on the structure-function characteristics of the pro-
tein was to investigate the occurrence of conserved
residues in the vicinity of the mutation. The sequence logo
revealed the presence of two highly conserved, charged
residues viz. E79 and R91 that occur downstream of the
insertion site. In addition to these, hydrophobic residues
occurring at 48, 51, 58, 61 63, 80, 81 and 82 positions and
glycine residues occurring just before the insertion site at
56 and 64th position are also conserved (Fig. 2). Hence,
Table 2: Description of the web-based tools used in the study
Tool Description URL Reference
WebLogo Sequence Logo http://weblogo.berkeley.edu/logo.cgi 41
FUGUE Template identification http://tardis.nibio.go.jp/fugue/prfsearch.html 28
JPRED Secondary structure prediction http://www.compbio.dundee.ac.uk/~www-jpred/ 26
GeneSilico metaserver Fold prediction metaserver https://genesilico.pl/meta2/ 25
SYMPRED Secondary structure prediction http://zeus.cs.vu.nl/programs/sympredwww/ 27
Verify3D Structure evaluation http://nihserver.mbi.ucla.edu/Verify_3D/ 30
COLORADO3D Structure evaluation http://asia.genesilico.pl/colorado3d/ 31
PSI-BLAST Homolog identification http://www.ncbi.nlm.nih.gov/blast/Blast.cgi 42Journal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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the mutation could cause a drastic change in the position
of these conserved residues and thus lead to loss of struc-
ture and function of the protein.
Secondary structure prediction
The secondary structures for human P450c21 were pre-
dicted using various online softwares (Table 2). Except for
a few regions, there was good agreement in the predic-
tions from the various servers (see Additional file 2).
There does not seem to be any discordance with the sec-
ondary structures predicted at the site of mutation (see
Additional file 2).
Identification of suitable template
Cytochrome P4502c5 of rabbit (PDB ID: 1DT6) was iden-
tified as the best template, for modeling the structure of
human P450c21, by FUGUE (Z-score of 33.12; "certain"
with 99% confidence). As compared to the other tem-
plates, it also showed full-length sequence alignment with
least number of gaps. The consensus predicted secondary
structural elements of human P450c21 also aligned fairly
well (see Additional file 3). There exists another experi-
mentally elucidated structure for rabbit P4502c5 [1N6B;
[44]] with a better resolution as compared to 1DT6. The
secondary structure compositions of both these PDB
entries are identical and the RMSD between them is 0.8 Å.
Hence, 1N6B was considered as the ideal template for
modeling of human P450c21. A theoretical structure of
human P450c21 (PDB ID: 2GEG) has been elucidated
using rabbit P4502c5 (PDB ID: 1N6B) as template [29].
This structure was thus used to represent the WT and also
serve as the template for modeling the MT.
Direct DNA sequencing of exon 2 of CYP21A2 gene Figure 1
Direct DNA sequencing of exon 2 of CYP21A2 gene. (A) Sequence of mutated allele showing heterozygous insertion in 
exon 2 resulting in additional three valine residues after codon 70. The inserted sequence and the corresponding valine resi-
dues are boxed. The site of insertion is indicated by an arrow. (B) The lower sequence corresponds to the wild-type allele 
showing three valine residues.Journal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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Validation of the theoretical structures
The Verify3D analyses of theoretical models of both WT
and MT revealed that most of the residues had a positive
score. For low-scoring regions of the model, it was
observed that the corresponding regions of the template
(1N6B) too shared a low score. The structural anomalies
could thus have been passed down from the template dur-
ing modeling (see Additional file 4). The structures were
also colour-rendered based on the Verify3D scores gener-
ated by the Colorado3D server. The major part of the
structures, in all the cases, had a good score (see Addi-
tional file 5).
Sequence logo depicting the conservation of residues near the insertion site Figure 2
Sequence logo depicting the conservation of residues near the insertion site. The triple valine insertion occurs at 
position 71. The insertion site is flanked by many conserved residues.
CαRMSD plot of P450c21 structure with respect to the starting conformation Figure 3
Cα-RMSD plot of the WT and MT P450c21 structures with respect to the starting conformation during the 
course of the simulation (A). The change in the potential energy of the WT and MT structures as a function of time. (B). 
WT and MT plots are rendered in black and red respectively. The figure was prepared using XMGRACE (38).Journal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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Structural implications of the insertion
Loss of structural stability
The WT and MT structures were subjected to MD simula-
tions. The RMSD analysis of the trajectory revealed that
the WT dynamics attained equilibration at around 3 ns
with an RMSD of around 0.5 nm, while the MT attained
equilibrium at around 6 ns with a higher RMSD (0.75 nm;
Fig. 3A). In concurrence to the above observation, the
potential energy of the MT remains higher through out the
dynamics as compared to the WT (Fig. 3B). The loss of the
secondary structures at the region near the insertion site
during the course of the simulation clearly reveals a faster
unfolding of the MT as compared to the WT (Fig. 4). All
these observations suggest that the triple valine insertion
causes an overall destabilization of the protein.
Loss of H-bond interactions at the vicinity of insertion
Further examination of the atomic-level interactions at
the vicinity of the insertion present in human P450c21
(WT) revealed that residues N72 and E79 participate in
hydrogen bonding with distantly placed residues viz. T52,
N387 and S374 (Fig. 5). Trajectory analysis revealed that
the hydrogen bond interactions between E79 and S374
seem to be destroyed in the early stages of simulation for
MT whereas these were retained in WT (see Additional file
6 part A). The hydrogen bonds between N72-N387 and
N72-T52 were also lost rapidly for the MT (see Additional
file 6 parts B and C).
Functional implications of the insertion
Heme and substrate-binding
Docking and homology studies of cytochrome P450s
have helped in identification of putative heme and sub-
strate-binding residues. The residues S108 and D287 have
thus been implicated in heme and substrate-binding [29].
These residues were seen to be interacting with each other
in P450c21. The change in distance between the Cα atoms
of these residues was monitored for the trajectories as a
function of time for both the WT and MT structures (Fig.
6A). The distance between these two residues in the native
WT and MT structures is 0.6 nm. It has to be noted here
that the starting structures for simulations of WT and MT
were identical except for the triple valine insertion and the
residues S108 and D287 were distantly placed from the
insertion site. In WT dynamics the distance between these
two residues was maintained at around 0.6 nm, while for
the MT the distance initially increased to around 2.25 nm
and later stabilizes at around 1.25 nm (Fig. 6A).
Hydrophobic interactions
Based on Optimal Docking Area method, three segments
corresponding to residues 30–42, 63–66 and 211–219 of
human P450c21 were found to form a surface exposed
Snapshots of the conformation of human P450c21, near the insertion site (residues 57–82), during the course of simulation Figure 4
Snapshots of the conformation of human P450c21, near the insertion site (residues 57–82), during the course 
of simulation. The top and bottom panels represent the WT and MT structures respectively as a function of time. The struc-
tures have been rendered using MolScript (40) and DSSP program (39) was used for acquiring the secondary structure infor-
mation.Journal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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hydrophobic patch [29]. It was hypothesized that these
residues would have to participate in hydrophobic inter-
actions to minimize the destabilizing effect caused by the
surface exposed hydrophobic region. Additionally, they
are positioned adjacent to the N-terminal transmembrane
region of the protein. Hence these hydrophobic residues
were suggested to be probably involved in binding with
the ER membrane [29]. These residues were considered as
a cluster and the RMS deviation of the Cα atoms of this
cluster with respect to the starting conformation was com-
pared for the WT and MT structures during the course of
simulation. It was observed that the RMS deviation
increased as a function of time for the MT as compared to
the WT (Fig. 6B).
Discussion
CAH is found in wide range of clinical severity ranging
from subtle hormone imbalance in adults to severe life
threatening salt wastage in newborns. Detection of under-
lying mutations in CYP21A2 gene encoding steroid 21-
hydroxylase enzyme is helpful both for confirmation of
diagnosis and management of CAH patients. Different
kinds of mutations result in different degrees of enzymatic
impairment of P450c21, which result in varied pheno-
types of CAH patients. Although, a large number of novel
mutations have been reported in CYP21A2 gene over the
past few years and these mutations have continued
expanding worldwide, large insertion/duplication muta-
tions are uncommon. A duplication of 16 bases (CCT-
GGATGACACGGTC) at codons 393–397 of exon 9 [45]
and a large duplication of 111 bases from codons 21 to 57
inserted at codon 58 in exon 1 of the CYP21A2 gene have
been reported [46]. Once a novel mutation is encoun-
tered, it is necessary to carry out the functional studies to
establish genotype – phenotype correlation so that the
prognostic evaluation can be made for the proper man-
agement of the patient.
A large number of mutations detected in CYP21A2 gene
have been characterized to prove their clinical relevance
and impact on P450c21 protein. For characterization of
mutations, functional studies have been carried out by site
directed mutagenesis followed by in vitro expression of the
mutant protein in transiently transfected mammalian
cells. The residual enzyme activity is then measured
towards both natural substrates (17-OHP and progester-
one) and compared with the WT protein. Percentage of
enzyme activity is correlated with the clinical phenotype
and accordingly the mutation is classified as SV, SW or NC
type [10,47-50]. However such studies are laborious, time
consuming and in some mutant proteins, the biochemical
and biophysical evaluation is not possible by in vitro stud-
ies. In such cases, in silico studies can provide additional
clinically useful information that could not be possible by
examining the patients [29]. Molecular modeling has
been used to study the putative effects of steroid 21-
hydroxylase gene mutations. Structural features deduced
from the models were in good correlation with clinical
severity of P450c21 mutants, which shows the applicabil-
ity of a modeling approach in assessment of new P450c21
mutations [29,51-54].
In this particular case, the 9-bp insertion/duplication did
not result in frameshift as expected from insertions/dupli-
cations in general; instead it led to insertion of three
valine residues between V70 and L71. Since this insertion
mutation does not exist in pseudogene, gene conversion
may not be the cause of this mutation. This duplication
might have been generated by intergenic recombination
during meiosis. Theoretically, this insertion could lead to
absence of residual 21-hydroxylase activity resulting in the
severe SW phenotype. Given the fact that CAH is an auto-
somal recessive disorder, the clinical severity reflects the
milder mutation present in the patient. Hence SV pheno-
type of our patient that reflected the mild mutation I172N
present on one allele, could not give additional informa-
tion about the possible structural perturbation caused by
the novel mutation present on the other allele. In such
compound heterozygous cases with a mild known muta-
Partial structure of human P450c21 depicting the residues  whose H-bond (dotted line) interactions get affected due to  mutation Figure 5
Partial structure of human P450c21 depicting the 
residues whose H-bond (dotted line) interactions get 
affected due to mutation. The structures in green and 
blue represent regions from 46–94 residues and 365–390 
residues respectively. The figure has been rendered using 
MolScript (40).Journal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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tion on one allele and a novel mutation on other allele, it
is difficult to classify the mutation on the basis of clinical
phenotype.
In the present study, molecular modeling and MD simu-
lations were carried out to analyze the structural conse-
quences of this insertion in P450c21 and to better
understand the molecular pathology of CAH in the
proband.
The structure of human P450c21 has not been experimen-
tally elucidated. However, a theoretical model for it is
available in the Protein Data Bank (PDB ID: 2GEG; [29]).
The accuracy of this theoretical model was ascertained
using structure prediction and evaluation tools (see Addi-
tional files 2, 3, 4, 5). Subsequently, using the WT as the
template, the structure of the MT was modeled.
Both the WT and MT structures were subjected to MD sim-
ulations for comparison of their structural stabilities. The
trajectory analyses were carried out to understand i) the
effect on the structural stability and ii) plausible func-
tional implications of the insertion.
Studies on the unfolding dynamics of the WT and MT
revealed that, although the two shared an identical start-
ing structure – except for the site of insertion, the MT
exhibits faster unfolding and is less stable (Figs. 3A–B). It
was also observed that the secondary structures are gradu-
ally lost at the site of insertion during the course of simu-
lation in the MT (Fig. 4). The observations indicate that
the insertion seems to have a profound effect on reducing
the intrinsic stability of human P450c21.
In the absence of experimental data, the interactions and
stability of the regions of the protein predicted to be har-
boring functional importance were selected for trajectory
analyses. Based on docking and homology studies of cyto-
chrome P450s, residues S108 and D287 have been impli-
cated in both heme and substrate-binding [29]. Docking
and structural studies have also helped in identification of
hydrophobic patches in human P450c21, which are sug-
gested to be involved in ER membrane binding [29]. The
results of the present simulation studies revealed that the
Cα distance between the residues S108 and D287 increase
drastically in the MT while it remains the same in the WT
(Fig. 3C). These residues are placed far away from the site
of insertion and yet their interactions seem to be affected
in the mutant. This indicates that the insertion of triple
valine seems to have caused not only a local structural per-
turbation but also a drastic disturbance in the structural
stability of protein. Similarly, in the case of the hydropho-
The change in Cα distances between the residues S108 and D287, both of which are postulated to be involved in heme and  substrate binding, as a function of time Figure 6
The change in Cα distances between the residues S108 and D287, both of which are postulated to be involved 
in heme and substrate binding, as a function of time. (A). Change in the CαRMSD plot of the hydrophobic patches with 
respect to the starting structure for WT and MT during the course of the simulation (B). WT and MT plots are rendered in 
black and red respectively. The figure was prepared using XMGRACE (38).Journal of Biomedical Science 2009, 16:3 http://www.jbiomedsci.com/content/16/1/3
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bic regions implicated in ER membrane binding, the
RMSD observed during the course of simulation suggested
that this region is highly unstable in the MT as compared
to the WT (Fig. 3D).
The sequence logo reveals that the insertion occurs in a
region flanked by the presence of many conserved resi-
dues (Fig. 2). This observation, along with the results of
the trajectory analyses, strongly suggests that the mutation
could lead to a loss of the structure and function of
human P450c21.
Conclusion
Analysis of CYP21A2 gene in an Indian child with classical
CAH, revealed a novel 9 base pair TGTGGTGGT insertion
at nucleotide position 306 in exon 2. This insertion
resulted in a triple valine insertion between V70 and L71
of P450c21. MD simulations revealed that this insertion
seems to cause an overall destabilization of the structure.
Although the insertion does not occur in the immediate
vicinity of the postulated heme and substrate binding res-
idues; trajectory analyses reveal that their interactions
seem to get disrupted in the MT. These observations indi-
cate that the insertion could result in SW phenotype had
it been present in homozygous state. We emphasise this
mutation should be added to the panel of mutations to be
screened in Indian population.
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Fig. S1. SeqScape view. (A) Reference sequence of CYP21A2 gene. 
(Higashi et al 1986). (B) Consensus sequence generated from forward 
and reverse strand. Highlighted region in grey shows insertion of 9 base 
pair. The vertical bar indicates the site of insertion. (C) Forward sequence 
of exon 2 of CYP21A2 gene. (D) Reverse sequence of exon 2 of CYP21A2 
gene. (E) Results of SeqScape showing heterozygous insertion of 9 bases 
at position 245 of the aligned sequence. Missense substitution at position 
53 and 73 are detected by the software due to noisy peaks.
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Fig. S2. Alignment of the secondary structures of human P450c21 
model with the secondary structures predicted using SYMPRED, 
JPRED and GeneSilico metaserver. The secondary structures are repre-
sented as black and blue highlights for helices (H) and strands (E) respec-
tively. The arrow indicates the site of mutation. The red box highlights the 
discordant predictions in the secondary structure.
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[http://www.biomedcentral.com/content/supplementary/1423-
0127-16-3-S2.tiff]
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Fig. S3. Sequence alignment of P4502c5 of rabbit (1DT6/1N6B) with 
human P450c21 generated by FUGUE server, along with their sec-
ondary structure information. The human P450c21 secondary structure 
is predicted using the online servers (Table 2). If two of the three servers 
have agreement for a secondary structure for a residue, then that second-
ary structure is taken as the consensus for that residue. The arrow indi-
cates the site of mutation. The consensus predicted secondary structure for 
human P450c21 is represented in the last row. The helical and strand res-
idues are depicted in red and blue respectively.
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[http://www.biomedcentral.com/content/supplementary/1423-
0127-16-3-S3.tiff]
Additional file 4
Fig. S4. Verify3D plot of the theoretical models of human P450c21 
(WT and MT) and template structure (rabbit P4502c5; 1N6B). Figure 
containing Verify3D plot of the theoretical models of human P450c21 
(WT and MT) and template structure (rabbit P4502c5; 1N6B).
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[http://www.biomedcentral.com/content/supplementary/1423-
0127-16-3-S4.tiff]
Additional file 5
Fig. S5. Structures rendered based on the Verify3D scores generated 
by Colorado3D. The region of triple valine insertion is highlighted by a 
box and the site of insertion is depicted by a pink star in MT. Blue and red 
colours indicate the best and worst scoring regions respectively. WT repre-
sents theoretical structure for human P450c21 (PDB ID: 2GEG) and the 
template denotes rabbit P4502c5 (PDB ID: 1N6B).
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